Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Diabetologia
|
April 7, 2007
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease
M Lassila, K Fukami, K Jandeleit-Dahm, et al.
Clinical and Experimental Immunology
|
October 12, 2011
Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis
S A Summers, R K S Phoon, D Odobasic, et al.
Clinical and Experimental Immunology
|
May 2, 2002
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis
A R Kitching, M Katerelos, S J Mudge, et al.
Clinical and Experimental Immunology
|
February 18, 2014
Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane
S A Summers, D Odobasic, M B Khouri, et al.
The Journal of Experimental Medicine
|
March 3, 1997
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis
A R Kitching, S R Holdsworth, V A Ploplis, et al.
Diabetologia
|
April 28, 2010
Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
A K H Lim, F Y Ma, D J Nikolic-Paterson, et al.
Clinical and Experimental Immunology
|
March 18, 2008
The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response
M Leech, J R Xue, A Dacumos, et al.
The American Journal of Pathology
|
June 1, 1995
Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy
T J Neale, B M Rüger, H Macaulay, et al.
Journal of Autoimmunity
|
September 3, 2010
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy
S A Summers, A Hoi, O M Steinmetz, et al.
JCI Insight
|
July 9, 2025
Gene therapy enhances deoxyribonuclease I treatment in antimyeloperoxidase glomerulonephritis
Anne Cao Le, Virginie Oudin, Jonathan Dick, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Diabetologia
|
April 7, 2007
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease
M Lassila, K Fukami, K Jandeleit-Dahm, et al.
Clinical and Experimental Immunology
|
October 12, 2011
Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis
S A Summers, R K S Phoon, D Odobasic, et al.
Clinical and Experimental Immunology
|
May 2, 2002
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis
A R Kitching, M Katerelos, S J Mudge, et al.
Clinical and Experimental Immunology
|
February 18, 2014
Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane
S A Summers, D Odobasic, M B Khouri, et al.
The Journal of Experimental Medicine
|
March 3, 1997
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis
A R Kitching, S R Holdsworth, V A Ploplis, et al.
Diabetologia
|
April 28, 2010
Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
A K H Lim, F Y Ma, D J Nikolic-Paterson, et al.
Clinical and Experimental Immunology
|
March 18, 2008
The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response
M Leech, J R Xue, A Dacumos, et al.
The American Journal of Pathology
|
June 1, 1995
Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy
T J Neale, B M Rüger, H Macaulay, et al.
Journal of Autoimmunity
|
September 3, 2010
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy
S A Summers, A Hoi, O M Steinmetz, et al.
JCI Insight
|
July 9, 2025
Gene therapy enhances deoxyribonuclease I treatment in antimyeloperoxidase glomerulonephritis
Anne Cao Le, Virginie Oudin, Jonathan Dick, et al.
Page
of 4